Haloperidol is an antipsychotic drug commonly used to treat a range of neurological disorders, including schizophrenia, Tourette syndrome, bipolar disorder and others. The drug works by blocking ...
Karuna Therapeutics focuses on developing therapies that target muscarinic cholinergic receptors to treat psychosis and cognitive impairment in CNS disorders. The Company's lead asset, KarXT, has ...
In its first Phase Three clinical test, an experimental antipsychotic medicine called lumateperone has shown evidence of being both effective and safe. That is the conclusion of a research team that ...
Please provide your email address to receive an email when new articles are posted on . Cobenfy is the first antipsychotic medication to treat schizophrenia by targeting cholinergic receptors. The ...
First-Generation Antipsychotic Drugs By Jonathan Scheff This table lists selected first-generation antipsychotic drugs. For a table of atypical agents, click here. For a table of the next generation ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Cobenfy (xanomeline/trospium chloride; formerly KarXT) was ...
Early in the course of the development of these agents, haloperidol was found to cause not only hypokinetic and hyperkinetic motor disorders but also a potentially fatal syndrome of muscle rigidity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results